{
     "PMID": "1284678",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19930702",
     "LR": "20151119",
     "IS": "0197-0186 (Print) 0197-0186 (Linking)",
     "VI": "20",
     "IP": "3",
     "DP": "1992 Apr",
     "TI": "c-fos mRNA in mouse brain after MPTP treatment.",
     "PG": "281-7",
     "AB": "The neurotoxin, MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induces a transient increase of mRNA for the immediate-early gene c-fos in the mouse brain. The c-fos mRNA level is MPTP dose-dependent and is evident in all brain regions tested including striatum, hypothalamus, cortex, hippocampus, cerebellum and midbrain. There are regional differences in the time-course for the rise of c-fos mRNA. Pretreatment with deprenyl, a selective monoamine oxidase B inhibitor, pargyline, a nonselective monoamine oxidase inhibitor, or mazindol, a dopamine uptake transport inhibitor, does not prevent the c-fos mRNA increase, suggesting that the elevation is due to the action of MPTP and not its neurotoxic metabolite MPP+.",
     "FAU": [
          "Duchemin, A M",
          "Gudehithlu, K P",
          "Neff, N H",
          "Hadjiconstantinou, M"
     ],
     "AU": [
          "Duchemin AM",
          "Gudehithlu KP",
          "Neff NH",
          "Hadjiconstantinou M"
     ],
     "AD": "Department of Pharmacology, Ohio State University College of Medicine, Columbus 43210.",
     "LA": [
          "eng"
     ],
     "GR": [
          "NS23627/NS/NINDS NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "England",
     "TA": "Neurochem Int",
     "JT": "Neurochemistry international",
     "JID": "8006959",
     "RN": [
          "0 (Neurotoxins)",
          "0 (RNA, Messenger)",
          "2K1V7GP655 (Selegiline)",
          "63231-63-0 (RNA)",
          "9MV14S8G3E (Pargyline)",
          "9P21XSP91P (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine)",
          "C56709M5NH (Mazindol)"
     ],
     "SB": "IM",
     "GS": [
          "c-fos"
     ],
     "MH": [
          "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/*pharmacology",
          "Animals",
          "Blotting, Northern",
          "Brain/drug effects/*metabolism",
          "Dose-Response Relationship, Drug",
          "*Genes, fos",
          "Kinetics",
          "Male",
          "Mazindol/pharmacology",
          "Mice",
          "Neurotoxins/*pharmacology",
          "Organ Specificity",
          "Pargyline/pharmacology",
          "RNA/isolation & purification",
          "RNA, Messenger/*metabolism",
          "Reference Values",
          "Selegiline/pharmacology",
          "Time Factors"
     ],
     "EDAT": "1992/04/01 00:00",
     "MHDA": "1992/04/01 00:01",
     "CRDT": [
          "1992/04/01 00:00"
     ],
     "PHST": [
          "1992/04/01 00:00 [pubmed]",
          "1992/04/01 00:01 [medline]",
          "1992/04/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Neurochem Int. 1992 Apr;20(3):281-7.",
     "term": "hippocampus"
}